论文部分内容阅读
目的:比较乳腺癌患者术后应用TEC方案与EC-T方案化疗对空腹的血糖影响。方法:回顾性研究TEC方案患者114例,EC-T方案患者99例,统计每例患者每周期化疗前空腹血糖,分析两种化疗方案对患者血糖的影响。结果:EC-T方案组有4例患者空腹血糖水平异常增高,TEC组有12例患者空腹血糖水平异常增高,两者比较差异有显著性。结论:EC-T方案升高患者空腹血糖水平的作用小于TEC方案,在病情允许情况下,尽可能将TEC方案改为EC-T方案,以降低患者化疗导致血糖升高甚至糖尿病的风险。
OBJECTIVE: To compare the effects of TEC and EC-T chemotherapy on fasting blood glucose in patients with breast cancer after operation. METHODS: A total of 114 patients with TEC regimen and 99 patients with EC-T regimen were retrospectively studied. The fasting blood glucose before chemotherapy was calculated weekly for each patient. The effects of two chemotherapy regimens on blood glucose were analyzed. Results: The fasting blood glucose level was abnormally elevated in 4 patients in the EC-T regimen group. The fasting blood glucose level was abnormally elevated in 12 patients in the TEC group. There was a significant difference between the two groups. CONCLUSION: The effect of EC-T regimen on fasting blood glucose level is less than that of TEC regimen. When possible, the TEC regimen should be changed to EC-T regimen to reduce the risk of chemotherapy-induced hyperglycemia and even diabetes.